Rare diseases
Investigational molecules
Locations
92 Park Drive, Milton, OX14 4RY, United Kingdom
Immunocore Limited supports clinical research in advanced uveal melanoma and previously treated non-ocular advanced melanoma, with a clear emphasis on T-cell receptor-based immunotherapy and immune checkpoint combinations.
The sponsor’s oncology portfolio is centered on treatment approaches for advanced melanoma populations with limited therapeutic options, including patients with metastatic disease and those requiring systemic immune-based therapy.
Immunocore Limited runs clinical trials in conditions such as Type 1 diabetes mellitus, Metastatic malignant melanoma, Uveal melanoma, HIV infection, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaAustria
BelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
